Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
1.560
-0.100 (-6.02%)
Oct 30, 2026, 1:47 PM EDT - Market open
Nkarta Market Cap
Nkarta has a market cap or net worth of $111.73 million as of October 30, 2026. It is the 23,901st most valuable company in the world and the 3,965th biggest in the United States. Its market cap has decreased by 33.06% in one year.
Market Cap
111.73M
Enterprise Value
2.51M
1-Year Change
-33.06%
Global Rank
Country Rank
#3,965 United States
Category
ChartMarket Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $111.73M, a decrease of -92.37%. That is a compound annual growth rate of -33.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 123.19M | -6.25% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 130.84M |
| TuHURA Biosciences | 128.73M |
| Foghorn Therapeutics | 125.90M |
| Outlook Therapeutics | 119.70M |
| Tiziana Life Sciences | 119.69M |
| Anavex Life Sciences | 119.12M |
| Armata Pharmaceuticals | 118.98M |
| NRx Pharmaceuticals | 118.54M |